Skip links

2nd TRP Target Selection & Drug Design Summit, Feb 21-24, 2026 in Boston, US

We’re excited to share that Randolf Kerschbaumer, CEO of OncoOne, will be speaking at the 2nd TRP Target Selection & Drug Design Summit 2026 in Boston, MA (Feb 24–26, 2026)!

This event brings together radiochemists, biologists, and R&D leaders to advance the science of targeted radiopharmaceuticals — from smarter target selection to innovative drug design strategies that could shape the next era of radioligand therapies.

Randolf will be presenting on pretargeting strategies to maximize tumor uptake while minimizing exposure to healthy tissue — an approach that directly builds on OncoOne’s PreTarg-it® platform, designed to enable highly precise and tolerable cancer therapies.

We look forward to engaging with experts across industry and academia to drive progress in radiopharmaceutical development and patient impact. 🌟